ZYBT
Zhengye Biotechnology Holding Limited
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CN
$1.61
−1.23%Institutional positioning
13F filings over the trailing two quarters
New 0Increased 2Reduced 5Sold out 8
| Filer | Action | Shares | Filed |
|---|---|---|---|
| XTX TOPCO LTD | Reduced | 44,146 | May 15, 2026 |
| WINTON GROUP LTD | Reduced | 33,389 | May 12, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Unchanged | 29,068 | May 15, 2026 |
| UBS GROUP AG | Reduced | 8,036 | May 5, 2026 |
| TOWER RESEARCH CAPITAL LLC (TRC) | Increased | 4,912 | May 15, 2026 |
| ROYAL BANK OF CANADA | Increased | 1,230 | May 15, 2026 |
| MORGAN STANLEY | Reduced | 261 | May 15, 2026 |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | Reduced | 1 | May 11, 2026 |
| Tower Research Capital LLC (TRC) | Sold Out | 0 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Sold Out | 0 | May 15, 2026 |
| ROYAL BANK OF CANADA | Sold Out | 0 | May 15, 2026 |
| XTX Topco Ltd | Sold Out | 0 | May 15, 2026 |
| Caitong International Asset Management Co., Ltd | Sold Out | 0 | May 11, 2026 |
| MORGAN STANLEY | Sold Out | 0 | May 15, 2026 |
| WINTON GROUP Ltd | Sold Out | 0 | May 12, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings